Professor, Regenerative Neurobiology, Department of Neuroscience, Uppsala University, 2016-present
Associate Professor, Regenerative Neurobiology, Department of Neuroscience, Uppsala University, 2010
Postdoctoral positions, Karolinska institutet, Stockholm, Sweden and National Institute for Medical Research, Mill Hill, London, UK.
PhD in Biology, 1991, Moscow State University, Russia
56 original publications and 7 review articles in PubMed
2 book chapters
Coordinator of EU-sponsored project within EuroNanoMed II, a partner in EU-sponsored project within the Joint Program in Neurodegenerative Disease, member of management committee COST Action Biomaterials and advanced physical techniques for regenerative cardiology and neurology.
Research profile: basic and translational research aimed at developing novel treatment strategies for spinal cord injury and disease, specifically ALS. The research exploits transplantation of human embryonic stem cell- or induced pluripotent stem cell-derived neural stem cells as well as implantation of nanoparticles as in vivo delivery systems for bioactive agents.
Professor, Regenerative Neurobiology, Department of Neuroscience, Uppsala University, 2016-present
Associate Professor, Regenerative Neurobiology, Department of Neuroscience, Uppsala University, 2010
Postdoctoral positions, Karolinska institutet, Stockholm, Sweden and National Institute for Medical Research, Mill Hill, London, UK.
PhD in Biology, 1991, Moscow State University, Russia
56 original publications and 7 review articles in PubMed
2 book chapters
Coordinator of EU-sponsored project within EuroNanoMed II, a partner in EU-sponsored project within the Joint Program in Neurodegenerative Disease, member of management committee COST Action Biomaterials and advanced physical techniques for regenerative cardiology and neurology.
Research profile: basic and translational research aimed at developing novel treatment strategies for spinal cord injury and disease, specifically ALS. The research exploits transplantation of human embryonic stem cell- or induced pluripotent stem cell-derived neural stem cells as well as implantation of nanoparticles as in vivo delivery systems for bioactive agents.